Provisional approval for 'Comirnaty' Pfizer Covid-19 mRNA Vaccine
Matt Shepherd made this Official Information request to Ministry of Health
This request has an unknown status. We're waiting for Matt Shepherd to read a recent response and update the status.
From: Matt Shepherd
Dear Ministry of Health,
The Comirnaty COVID-19 mRNA Pfizer vaccine is listed on the Medsafe website as having current approval under Section 23 of the Medicines Act.
Section 23 of the Medicines Act allows for the Minister to give provisional consent to the sale or supply or use of a new medicine where he is of the opinion that it is desirable that the medicine be sold, supplied, or used on a restricted basis for the treatment of a limited number of patients.
As Section 23 of the Medicines Act does not allow for this new vaccine to be used by the entire population of New Zealand, please provide the following information:
What is the limited number of patients who can receive treatment with this medicine while it is under the status of 'provisionally approved'?
To Clarify, I want to know the SPECIFIC number value that represents the "limited number of patients who can receive treatment with this medicine while it is under the status of 'provisionally approved'"
Yours faithfully,
Matt Shepherd
From: OIA Requests
Kia ora Matt,
Thank you for your email. This part of the Medicines Act 1981 is being
updated, further information can be found here:
[1]https://www.beehive.govt.nz/release/tech....
Under section 28(3) of the Act you have the right to ask the Ombudsman to
review any decisions made under this request. The Ombudsman may be
contacted by email at: [2][email address] or by calling 0800
802 602.
Ngā mihi
OIA Services Team
[3]Ministry of Health information releases
[4]Unite against COVID-19
------------------------------------------------------------------------
From: Matt Shepherd <[FOI #17252 email]>
Sent: Monday, 18 October 2021 18:39
To: OIA Requests <[email address]>
Subject: Official Information request - Provisional approval for
'Comirnaty' Pfizer Covid-19 mRNA Vaccine
Dear Ministry of Health,
The Comirnaty COVID-19 mRNA Pfizer vaccine is listed on the Medsafe
website as having current approval under Section 23 of the Medicines Act.
Section 23 of the Medicines Act allows for the Minister to give
provisional consent to the sale or supply or use of a new medicine where
he is of the opinion that it is desirable that the medicine be sold,
supplied, or used on a restricted basis for the treatment of a limited
number of patients.
As Section 23 of the Medicines Act does not allow for this new vaccine to
be used by the entire population of New Zealand, please provide the
following information:
What is the limited number of patients who can receive treatment with this
medicine while it is under the status of 'provisionally approved'?
To Clarify, I want to know the SPECIFIC number value that represents the
"limited number of patients who can receive treatment with this medicine
while it is under the status of 'provisionally approved'"
Yours faithfully,
Matt Shepherd
-------------------------------------------------------------------
This is an Official Information request made via the FYI website.
Please use this email address for all replies to this request:
[FOI #17252 email]
Is [Ministry of Health request email] the wrong address for Official Information requests
to Ministry of Health? If so, please contact us using this form:
[5]https://scanmail.trustwave.com/?c=15517&...
Disclaimer: This message and any reply that you make will be published on
the internet. Our privacy and copyright policies:
[6]https://scanmail.trustwave.com/?c=15517&...
If you find this service useful as an Official Information officer, please
ask your web manager to link to us from your organisation's OIA or LGOIMA
page.
-------------------------------------------------------------------
****************************************************************************
Statement of confidentiality: This e-mail message and any accompanying
attachments may contain information that is IN-CONFIDENCE and subject to
legal privilege.
If you are not the intended recipient, do not read, use, disseminate,
distribute or copy this message or attachments.
If you have received this message in error, please notify the sender
immediately and delete this message.
****************************************************************************
--------------------------------------------------------------------------
This e-mail message has been scanned for Viruses and Content and cleared
by the Ministry of Health's Content and Virus Filtering Gateway
--------------------------------------------------------------------------
References
Visible links
1. https://www.beehive.govt.nz/release/tech...
2. mailto:[email address]
3. https://www.health.govt.nz/about-ministr...
4. https://covid19.govt.nz/
5. https://scanmail.trustwave.com/?c=15517&...
6. https://scanmail.trustwave.com/?c=15517&...
hide quoted sections
Things to do with this request
- Add an annotation (to help the requester or others)
- Download a zip file of all correspondence
Paul Jones left an annotation ()
Note that the the Ministry lost the court case that challenged the provisional approval of pfizer under the "limited number" usage. Their response was to change the law 24 hours later and grant retroactive approval.
See an overview here https://www.nzherald.co.nz/nz/covid-19-c...
Link to this